This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Salesforce.com (CRM) Moves 6.1% Higher: Will This Strength Last?
by Zacks Equity Research
Salesforce.com (CRM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
How Much Upside is Left in Simulations Plus (SLP)? Wall Street Analysts Think 77.52%
by Zacks Equity Research
The consensus price target hints at a 77.5% upside potential for Simulations Plus (SLP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Simulations Plus' Q4 Earnings Top Estimates on Solid Revenue Growth
by Zacks Equity Research
SLP's fiscal fourth-quarter performance is driven by healthy revenue growth across its software and services business segments.
Simulations Plus (SLP) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Simulations Plus (SLP) delivered earnings and revenue surprises of 50% and 5.12%, respectively, for the quarter ended August 2024. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx (OPRX) Moves 5.4% Higher: Will This Strength Last?
by Zacks Equity Research
OptimizeRx (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Simulations Plus (SLP) Restructures Business Unit Post-Acquisitions
by Zacks Equity Research
Simulations Plus (SLP) enhances its business structure after recent acquisitions, and appoints new leaders for its redesigned business units
Implied Volatility Surging for Simulations Plus (SLP) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Simulations Plus (SLP) stock based on the movements in the options market lately.
Simulations Plus (SLP) Ties Up With ICCS for Chemical Safety
by Zacks Equity Research
Simulations Plus (SLP) announces a collaboration with ICCS on a research initiative to advance animal-free safety assessment of new chemicals
Simulations Plus (SLP) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Simulations Plus' (SLP) fiscal third-quarter revenues are driven by strength in Software and Services units.
Analysts Estimate Simulations Plus (SLP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Simulations Plus (SLP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.